BNTX maleate salt hydrate

BNTX, a selective nonpeptide σ1 opioid receptor (DOR1) antagonist, is used in σ opioid receptor research to help differentiate and characterized the function and role of the σ1 opioid receptor versus other σ opioid receptor subtypes. BNTX was used to help define the role of σ1 opioid receptors in neurological processes such as anxiety. It was used to help define the role of σ opioid receptors in myocardial infarct development and size.

BNTX is a selective d1 non peptide opioid receptor antagonist.

BNTX is a selective nonpeptide δ₁ opioid receptor antagonist. It antagonizes the effect of D-Pen^2,5-enkephalin (a δ₁ agonist 4-6 fold, but did not affect the activity of δ₂ or μ agonists.<<<107>>> BNTX is used to discriminate among opioid receptor subtypes in effects such as alcohol and drug dependence. It binds 100× more tightly to δ₁ than to δ₂ receptors. In the tail-flick assay, antinocieceptive ED50 = 646.4 pmol/mouse.

This compound is featured on the Opioid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.